Melika Lotfi
Oncology · 2020
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 6 citations into it
Whom Melika Lotfi trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Charles M. Rice (in Immunology)
Papers from Melika Lotfi's perspective
Ordered by how strongly the researchers Melika Lotfi trusts endorse each paper. Same corpus, a different order for every researcher.
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications (Nature Immunology)
- Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection (Gastroenterology)
- Interferon-Stimulated Genes: A Complex Web of Host Defenses (Annual Review of Immunology)
- Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak (Journal of Travel Medicine)
- The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status (Military Medical Research)
- Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia (Radiology)
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro (Antiviral Research)
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (New England Journal of Medicine)
- [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. (Journal of the American Medical Association (JAMA))
Their papers
- COVID-19: Transmission, prevention, and potential therapeutic opportunities (2020) — 815 citations